servation alone, but this type of lesion carries a risk of sudden visual deterioration in the event of acute thrombosis of the fistula. 33 Manual carotid-jugular compression has been advocated as a treatment option, with a complete cure rate of 34%, but such a maneuver may precipitate a vasovagal attack, ischemic stroke, or brachial plexus injury. 13, 19 Various modalities are currently available to treat DCCF, such as endovascular procedures with transvenous, transarterial, or transarterial-transfistulous embolization; 1, 8, 27, 32 surgery to obtain access to the fistula for embolization on either the venous or arterial side or to excise the fistula; 7, 16 radiosurgery (GKS 12 or XKnife radiosurgery
31
); or a combination of the 3 treatment modalities.
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Current treatment is primarily endovascular, and the transvenous route resulted in high clinical and anatomical cure rates and a lower incidence of complications. 17, 37 Transvenous embolization usually was used in patients in need of immediate alleviation of symptoms; however, a transvenous procedure indeed jeopardized the patients who were at risk of an intracerebral hemorrhage due to venous ruptures or newly developed cranial nerve palsy by the cavernous sinus embolization. In contrast, radiosurgery has a low risk of serious complications, but can take 3 months or longer to produce a therapeutic effect. Radiosurgery is generally used in patients with DCCF who have mild symptoms. 12, 31 Hence, the selection of treatment either with embolization or radiosurgery must be made according to clinical presentation and neuroimaging findings (for example, cerebral angiography, CT scanning and/or CT angiography, or MR imaging and/or MR angiography).
In this study, we retrospectively analyzed our results in patients with DCCFs treated with either XKnife or GKS. In particular, we focused on the treatment efficacy, clinical presentations, imaging findings, and adverse effects.
Methods

Patient Population
Data on 47 patients harboring DCCFs who were treated between September 2000 and August 2008 were retrieved from our radiosurgical database. Six patients were lost to follow-up, and thus were excluded from this study. Fifteen of the patients in this study were treated with XKnife radiosurgery and 26 were treated with GKS. The details of patient characteristics are given in Table 1 .
The clinical presentation included 40 patients with chemosis and proptosis (15 XKnife, 25 GKS) accompanied with increased intraocular pressure in 5 cases (3 XKnife, 2 GKS), cranial nerve VI palsy in 9 (2 XKnife, 7 GKS), and a combination of cranial nerve VI and III palsy in 4 (2 XKnife, 2 GKS). There was 1 patient with only a cranial nerve III palsy (Fig. 1) . The lateralization of symptoms was 19 over the right side (15 XKnife, 4 GKS), 18 on the left side (18 GKS), and 4 with symptoms that were bilateral (4 GKS).
The location of the fistula included 16 on the right side (4 XKnife, 12 GKS), 12 on the left side (4 XKnife, 8 GKS), and 13 that were bilateral (7 XKnife, 6 GKS). The classification of cerebral angiography findings according to the system of Barrow et al.
3 consisted of 4 patients with Type B (4 GKS), 2 with Type C (1 XKnife, 1 GKS), and 35 with Type D (14 XKnife, 21 GKS) ( Table 2) . Among the 41 patients, 6 had previously been treated with transarterial embolization (6 GKS), 1 with prior GKS (Fig. 2) , and 1 harboring a fistula directly between the CA and cavernous sinus without any treatment (Fig. 3) . In cases of transarterial embolization, only partial obliterations of branches from the ECA were performed to alleviate the symptoms and signs in 2 patients with high intraocular pressure and in 4 patients with chemosis accompanied by severe proptosis.
Treatment Modality and Radiosurgical Dose Planning
From September 2000 to September 2003, XKnife radiosurgery was the instrument we used for treatment (Clinical 21 EX, Varian Medical System), and for every patient we performed quality accuracy assurance each time. 6 From October 2003 to August 2008, the Gamma Knife model C (Elekta Instruments AB) was the radiosurgical device used to treat patients. The beam accuracy measurement was performed using an accurately machined testing tool provided by each of the manufacturers. The quality assurance was conducted once a month.
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High-resolution biplanar and stereotactic cerebral angiography that included selective vertebral artery, ICA, and ECA injection where appropriate was used for radiosurgical targeting and planning. Magnetic resonance imaging and MR angiography examinations, including T1-weighted, T2-weighted, TOF, spoiled gradient recall, and Gdenhanced sequences, were obtained to localize the nidus. The MR imaging and cerebral angiography results were transferred to the XKnife radiosurgical workstation (STP 4, Stryker Leibinger) or the Leksell GammaPlan station (Elekta Instruments AB). The targets were delineated on the fused MR imaging and MR angiography images. The various treatment modalities are detailed in Table 3 . The determination of radiosurgical targets in DCCFs was based on results of the cerebral angiogram assisted by MR and/or MR angiography imaging. In cases of bilateral DCCF supplied by bilateral CAs, 2 targets over both cavernous sinuses were determined (Fig. 4) . If single DCCFs were supplied by the ipsilateral CA or additional vessels by way of intercavernous veins from the opposite CA, a single target was determined (Fig. 5) .
Clinical and Imaging Follow-Up
Patients were followed up in our ophthalmological and neurosurgical outpatient clinics at 2-3 months postradiosurgery. The clinical data obtained at follow-up included intraocular pressure, visual acuity, and a detailed neurological examination.
Follow-up MR imaging and/or angiography was performed 3 months after radiosurgery and then at intervals of 6 months. The MR imaging sessions included T1-weighted, T2-weighted, TOF, and Gd-enhanced sequences to compare with pretreatment imaging. These MR imaging and/or angiography studies were used to evaluate the obliteration of the fistula and to detect any unintended postradiosurgery effects seen on MR imaging. Additional angiography was performed in patients whose symptoms were not completely resolved. The imaging was reviewed by a neuroradiologist, based on the previously reported criteria. 
Statistical Analysis
The descriptive statistics were computed using standard methods to calculate the mean or median values. In calculating discrepancies of treatment modalities between the XKnife and GKS, the Student t-test was used for analysis. A p value less than 0.05 was considered to be statistically significant.
Results
Clinical and Imaging Outcome
The mean age of the patients was 63 ± 2.6 years, with a male/female ratio of 9:32. The mean follow up period was 63.1 ± 4.4 months. The duration of symptom alleviation was 3.2 ± 0.3 months in the whole series (3.4 ± 0.4 months and 2.8 ± 0.3 months for XKnife and GKS, respectively). Thirty-seven (90%) of 41 patients achieved DCCF obliteration (93% for XKnife and 88% for GKS). Symptoms in 34 (85%) of 40 patients with chemosis or proptosis were alleviated. Among the cases in which radiosurgery failed, 4 patients still had residual fistulas and 2 had arterialization of sclera without evidence of fistula, as seen on repeat cerebral angiography. All 5 patients who had increased intraocular pressure were cured by the treatment. Ten (71%) of 14 patients with cranial nerve palsy were clinically improved following treatment. In 4 (80%) of 5 patients with imaging findings of cortical vein reflux, their symptoms were improved by radiosurgery (Fig. 6) . Three of 4 patients in the GKS group and 1 in the XKnife group with cortical vein drainage were cured by radiosurgery. In this failed treatment case, the reduced flow in cortical vein reflux was observed. The treatment outcomes are detailed in Table 4 .
Discrepancies of Treatment Modalities Between XKnife and GKS
Significant discrepancies of treatment modalities existed between the XKnife and GKS groups, such as radiation volume (5.68 ± 1.72 ml vs 1.69 ± 0.27 ml), conformity index (3.08 ± 0.26 vs 1.61 ± 0.12), number of isocenters (3.2 ± 0.46 vs 7.57 ± 0.73), instrument accuracy (0.56 ± 0.04 mm vs 0.146 ± 0.009 mm), and maximum dosage (27.1 ± 1.44 Gy vs 33.7 ± 0.67 Gy), with corresponding percentages at the peripheral isodose line (65 ± 3.3% vs 55 ± 1.6%). Significant radiation dosage differences also occurred over the right versus left lens (0.96 ± 0.07 Gy vs 0.51 ± 0.07 Gy/0.89 ± 0.09 Gy vs 0.48 ± 0.06 Gy), right versus left optic nerve (6.28 ± 0.38 Gy vs 3.9 ± 0.35 Gy/6.5 ± 0.24 Gy vs 3.23 ± 0.3 Gy), optic chiasm (5.9 ± 0.33 Gy vs 2.8 ± 0.24 Gy), brainstem (10.1 ± 0.39 Gy vs 7.2 ± 0.6 Gy), and maximum dose in cavernous sinus (27.1 ± 1.44 Gy vs 33.7 ± 0.67 Gy). Twelve-Gy volumes in the right temporal lobe (0.77 ± 0.18 ml vs 0.38 ± 0.09 ml), left temporal lobe (0.69 ± 0.21 ml vs 0.21 ± 0.06 ml), and brainstem (0.0096 ± 0.004 ml vs 0.0013 ± 0.001 ml) also showed the same trends. The details of our results and statistical analysis were depicted in Table 3 .
Adverse Reaction
In the assessment of the ophthalmological status of patients postradiosurgery, there was no development of new or worsening of existing cranial nerve palsy. However, there was 1 patient who developed optic neuritis treated by GKS, and the symptoms were alleviated by the steroid treatment (Fig. 7) . In the XKnife treatment group, there was 1 patient with an ICH and 1 in whom brainstem edema developed, both of which cases had been previously published by our group. 31 Furthermore, in 3 patients (20%) temporal lobe radiation edema developed after the XKnife treatment without causing significant symptoms (Fig. 6) . However, there was no adverse effect of radiation in the temporal lobe regions observed in the GKS group.
Discussion
Transvenous embolization for DCCF is a well-established treatment, but such endovascular treatment carries the risk of permanent complications in difficult cases. In cases of intractable or progressive symptoms or in the presence of retrograde cortical venous drainage, immediate embolization was mandatory. 8, 16, 27, 32 However, less invasive and slow response treatment such as radiosurgery was preserved for patients who had severe medical illness, unsuccessful embolization, or low-flow DCCF.
12,28
In the current study we present the successful treatment of The GKS treatment was performed with a delivery of 17 Gy to 50% isodose line, with the optic apparatus receiving less than 7.5 Gy. L: Posttreatment MR angiography study obtained 2 years later revealing total occlusion of the fistula. However, the chemosis was persistent.
DCCF by radiosurgery with either the XKnife or Gamma Knife in cases of patients without immediately neurologically threatening symptoms and signs.
Radiosurgery alone or assisted with embolization achieved a high complete obliteration rate; from 80% to 100%. 12, 22, 28, 31 This study demonstrates the feasibility of radiosurgery as a first-line treatment in DCCF. The choice of embolization, radiosurgery, or the combination of the 2 in the treatment of a particular patient with DCCF is optimally made by a multidisciplinary team and based on the clinical presentation and imaging findings. Radiosurgery, including XKnife or GKS, which caused the progressive intimal hypertrophy of the vessel wall, with subsequent thrombosis of the DCCF, is considered an alternative treatment, especially for patients without immediate alleviation of symptoms and signs. 12, 28, 31 In this study, the symptom alleviation typically started 3 months after radiosurgery, and MR imaging showed the total obliteration of the fistula at approximately 6 to 9 months, which is compatible with previous reports. 12, 18, 31 The symptoms of chemosis and proptosis were typically relieved after obliteration of the DCCF. However, a significant proportion of The GKS was targeted on both cavernous sinuses, with a total irradiation volume of 3.7 ml. Eighteen Gy to 50% line was delivered, with optic apparatus receiving < 4.7 Gy. O and P: Posttreatment MR angiography study obtained in lateral and axial views 6 months after GKS, revealing total obliteration of the fistula. Chemosis over both eyes was resolved; however, bilateral cranial nerve III and VI palsies were persistent. cranial nerve palsies did not return to normal functioning. This phenomenon was compatible with the reports on transvenous embolization 17, 37, 39 or radiosurgical treatment.
12,28,31
Furthermore, the new onset of cranial nerve palsy following a transvenous embolization was not observed following treatment with either the XKnife or GKS. 39 Other than the slowness of the resolution of symptoms and signs, radiosurgery seems to be an attractive alternative treatment for DCCF, especially for patients without immediate lifethreatening conditions or neurological risk status.
Approximately 30% of patients with arteriovenous malformations develop T2-weighted changes on MR imaging following GKS, with 1%-3% developing permanent neurological deficits. 35 Because there are few reports of DCCF treated with radiosurgery, the incidence of radiosurgery-associated complications, including postradiosurgical changes on MR imaging and permanent neurological deficits, is unknown. 2, 12, 18, 31 From large consecutive series of arteriovenous malformations treated with GKS, adverse changes are related to the radiation volume and dose. Flickinger et al. 9 reported that a 12-Gy volume significantly correlated with postradiosurgery imaging changes. In our study, 3 (20%) of 15 patients developed temporal lobe changes on MR imaging following treatment with XKnife radiosurgery. This may have resulted in the significantly larger 12-Gy treatment volume by XKnife over that of the Gamma Knife. In a previously published case of brainstem edema following treatment with the XKnife, radiosurgically induced brainstem edema is thought to originate from the alteration of venous flow caused by the direct radia- (0) tion effect. 31, 36 There was, however, no significant difference in neurological deficits observed in the 2 cohorts of patients. Long-term follow-up of these patients is essential. The latent effect of radiation-induced imaging alteration may predispose patients to the possibility of late cyst formation. 30 Hence, the refinement of treatment planning with avoidance of reduction in the volume of tissue irradiated is important to improve radiosurgical outcomes.
The accuracy of imaging techniques and the steep dose gradient of radiosurgery serves to protect the optic apparatus and brainstem from high-dose irradiation. 12 In the current study, the optic apparatus received a radiation dose less than 8 Gy, which has been regarded as a safe dose for the optic pathways. Other cranial nerves in the cavernous sinus are generally more resistant to radiation injury than the optic nerve. It had been reported that these nerves may tolerate up to 40 Gy in single fraction. 24 In the present study, the maximum dose delivered to the cavernous sinus was 32 ± 0.8 Gy. In this study, we found that a significantly higher radiation dose was delivered to the optic apparatus in the XKnife group than in the GKS group. Thus, it was expected that a higher incidence of optic nerve neuritis should occur in the XKnife group. Counterintuitively, 1 Gamma Knife-treated patient developed optic neuritis, even though this patient's optic apparatus received a radiation dose less than 5.4 Gy. Hence, a refinement of dose planning to reduce as much as possible the radiation exposure of the optic nerve remains an important goal for improving radiosurgical outcomes for DCCFs.
Theoretically, the biological effects of these 2 radiosurgery devices (XKnife and Gamma Knife) should be comparable. 34 However, GKS has some advantages over XKnife radiosurgery. These included improved accuracy, ease of use, shorter dose planning time, and fewer corrective procedures required in treatment preparation. Most importantly, using GKS, a more conformal treatment plan can be achieved using multiple isocenters and thereby, adjacent structures should have lower radiation exposure. Using XKnife radiosurgery, achieving high conformality and a steep gradient index can be difficult to accomplish due to time constraints and technical complexity. 25 In this study, there was a significant difference of conformity index between these 2 methods.
Gamma Knife radiosurgery is the most accurate method of radiosurgery available, with beam accuracy within 0.2 mm. 40 This cannot be achieved using XKnife radiosurgery. Our data showed that the Gamma Knife, with its accuracy of 0.146 ± 0.009 mm, had a higher accuracy than that of the XKnife, at 0.56 ± 0.04 mm. Despite the advantages of GKS, XKnife radiosurgery also has some advantages. It can be applied to the whole body and is not limited to the brain. It is cheaper. Additionally, XKnife radiosurgery is appropriate for a wide range of targets, including very low and lateral ones in the cranium, where the XKnife may be the method of choice. 20, 26 With the introduction of the Gamma Knife Perfexion model, the Gamma Knife can now be used to easily reach below the foramen magnum and laterally in the skull.
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Cerebral angiography gives dynamic views of the cerebral vasculature in multiple projections regardless of blood flow velocity. It is superior in evaluating obliteration of DCCFs. However, due to the small risk of complications from angiography, we more commonly used noninvasive MR imaging and/or MR angiography for the follow-up imaging. Consequently, it could be argued that the obliteration rate of DCCF in our study, as assessed by MR angiography, may be overestimated. In previous reports, comparisons of MR imaging and cerebral angiography showed angiography to have a higher detection rate for DCCF.
12,15 However, Hirai et al. 14 and Ouanounou et al. 29 have reported that TOF MR angiography is at least as sensitive as conventional angiograms, and may have a higher false-positive rate. We could not perform angiography for final confirmation in many instances. However, MR angiography/MR imaging probably provided reliable information for the assessment of obliteration of DCCF and treatment-related complications.
Most of the patients in this study were reluctant to undergo posttreatment cerebral angiography due to the fact that their symptoms and signs were cured. A post- GKS angiogram was only performed in patients in whom MR imaging and/or MR angiography findings were normal, but who still had symptoms and signs of DCCF or incomplete obliteration of the nidus observed on followup neuroimages. As a result, there potentially existed the risk of incorrectly judging whether there was complete obliteration of the fistula, and especially of missing cortical venous drainage.
Conclusions
Both GKS and XKnife radiosurgery yielded a satisfactory rate of obliteration of DCCFs and a low rate of complications. There were significant differences between these 2 groups, including radiation volume, conformity index, number of isocenters, instrument accuracy, and maximum dosage with corresponding isodose lines. Subsequently, significantly higher doses delivered to the lens, optic nerve, chiasma, and brainstem were observed in the XKnife group. These higher radiation doses to critical structures in the XKnife cohort may be responsible for the higher incidence of postradiation changes seen in this group.
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